JERSEY CITY, NJ — October 22, 2008 - QUMAS, a leading provider of regulatory compliance solutions, today announced that Ferndale Laboratories, Inc. who are committed to creating therapies that help heal, protect and beautify the skin, has selected QUMAS DocCompliance™ as its enterprise regulatory content management system for Regulatory Affairs, Quality Assurance, and Manufacturing.
"Ferndale Laboratories set out to find a user-friendly e-document system to transition from a paper-based document management system," said Richard Hamer, Vice President, Regulatory/Clinical Affairs and Quality Assurance "QUMAS met all of our needs including a comprehensive validation package, highly customizable reports and rapid document retrieval. We look forward to working with the QUMAS team."
"QUMAS is providing Ferndale with an end to end solution that brings their paper-based documents under control in DocCompliance, enabling them to go into production with a validated system containing a wealth of content," said Murtuza Vasowalla, Director of Solution Consultants at QUMAS. "Along with targeted training, this will ease the process of user adoption across the enterprise, and will bring the company into traceable compliance in their required timeframe".
QUMAS is the leader in Compliance Solutions with more than 250 customer deployments, and over a decade of experience helping companies in highly regulated industries provide a proactive regulatory defense. QUMAS solutions for life sciences are designed to achieve compliance with industry and government standards for 21 CFR Part 11, cGxP, Quality, R&D, Regulatory Affairs and Clinical Operations. QUMAS enables organizations to bring new drugs to market faster with better quality submissions while proactively managing regulated content and controls, reducing costs, and improving customer satisfaction.
For more information visit www.qumas.com
About Ferndale Laboratories
Founded in 1897 as the J.F. Hartz Company, Ferndale Laboratories originally served the medical profession by providing surgical instruments. In October 1950, the J.F Hartz Company moved to its present location in Ferndale, Michigan. Its focus then shifted to serving Michigan doctors and hospitals through surgical and pharmaceutical divisions. Ferndale Laboratories, Inc. has over 100,000 square feet of manufacturing, warehouse and office space dedicated to achieving the latest technological advances in the manufacturing of healthcare products.
For more information visit www.ferndalelabs.com
# # #
All trade names, trademarks, and service marks are the rightful property of their respective owners.